Literature DB >> 14593432

M129V variation in the prion protein may influence cognitive performance.

D Rujescu1, A M Hartmann, C Gonnermann, H-J Möller, I Giegling.   

Abstract

Correlations between general intelligence (g) and brain volume are about 0.40, and the correlation between g and white matter volume has been reported to be largely due to genetic factors. Establishing that the correlation between brain volumes and cognitive abilities is mediated by shared genetic factors is only the first step in unveiling the relation between them. We have recently shown that methionine at codon 129 in the prion protein is associated with white matter reduction in a group of healthy volunteers and schizophrenic patients. The present study examines the influence of the same genetic variation on psychometric cognitive performance measurements in 335 community-based healthy volunteers. The polymorphism was associated with Full Scale IQ (genotype: F=4.38, df=2/317, P=0.013; allele: F=8.04, df=1/658, P=0.005), as measured by HAWIE-R (German version of the Wechsler Adult Intelligence Scale, Revised). Genotype accounted for 2.7% of the total variability in Full Scale IQ (partial eta2=0.027). An exploratory analysis revealed association with several HAWIE-R subscales; the association with the Digit Symbol subtest remained significant after correction for multiple testing. In summary, we deliver evidence for an association of a common genetic variation in the prion protein gene with cognitive performance. However, independent replications are needed before firm conclusions can be drawn.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593432     DOI: 10.1038/sj.mp.4001327

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  8 in total

1.  A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder.

Authors:  Jonathan Savitz; Lize van der Merwe; Mark Solms; Rajkumar Ramesar
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.

Authors:  Hans-Jürgen Möller
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

3.  The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians.

Authors:  Ewa Golanska; Monika Sieruta; Elizabeth Corder; Sylwia M Gresner; Anna Pfeffer; Malgorzata Chodakowska-Zebrowska; Tomasz M Sobow; Izabela Klich; Malgorzata Mossakowska; Aleksandra Szybinska; Maria Barcikowska; Pawel P Liberski
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

Review 4.  Alzheimer's disease and prion protein.

Authors:  Jiayi Zhou; Bingqian Liu
Journal:  Intractable Rare Dis Res       Date:  2013-05

Review 5.  Between destiny and disease: genetics and molecular pathways of human central nervous system aging.

Authors:  Christin Glorioso; Etienne Sibille
Journal:  Prog Neurobiol       Date:  2010-12-02       Impact factor: 11.685

Review 6.  The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

Review 7.  The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009.

Authors:  Antony Payton
Journal:  Neuropsychol Rev       Date:  2009-09-19       Impact factor: 7.444

Review 8.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.